<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MYA Space | Fulton Lynch | Activity</title>
	<link>https://space.mya.co.uk/members/backoption19/activity/</link>
	<atom:link href="https://space.mya.co.uk/members/backoption19/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Fulton Lynch.</description>
	<lastBuildDate>Wed, 30 Sep 2026 22:47:44 +0100</lastBuildDate>
	<generator>https://buddypress.org/?v=10.2.0</generator>
	<language>en-GB</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4a559d7a1552caa5fa14b1643b0e0d27</guid>
				<title>Fulton Lynch posted an update: We retrospectively assessed the actual tolerability as well [&#133;]</title>
				<link>https://space.mya.co.uk/activity/p/1654426/</link>
				<pubDate>Mon, 16 Oct 2023 10:09:07 +0100</pubDate>

									<content:encoded><![CDATA[<p>We retrospectively assessed the actual tolerability as well as efficiency regarding fractionated overall entire body irradiation (TBI) (1,200 cGy) and melphalan (MEL) (100-110 mg/m(A couple of)) myeloablative fitness within Forty eight patients together with nonremission AML (and Equates to 14), Just about all (d Is equal to 15), National hockey&hellip;<span class="activity-read-more" id="activity-read-more-1654426"><a href="https://space.mya.co.uk/activity/p/1654426/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a24a0df26fdc568872752b1a2ce6de9b</guid>
				<title>Fulton Lynch posted an update: In this assessment, we all explain "classical" serotyping [&#133;]</title>
				<link>https://space.mya.co.uk/activity/p/1645773/</link>
				<pubDate>Sun, 15 Oct 2023 18:08:17 +0100</pubDate>

									<content:encoded><![CDATA[<p>In this assessment, we all explain &#8220;classical&#8221; serotyping methods, accompanied by an account associated with genotyping as well as post-genomic keying in approaches. (H) 09 Elsevier B.Sixth is v. Most protection under the law reserved.A new limitation involving proteomic approaches regarding their particular scientific applicability may be the&hellip;<span class="activity-read-more" id="activity-read-more-1645773"><a href="https://space.mya.co.uk/activity/p/1645773/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b28d34cb82f43164143f074d09fa09b2</guid>
				<title>Fulton Lynch became a registered member</title>
				<link>https://space.mya.co.uk/activity/p/1645545/</link>
				<pubDate>Sun, 15 Oct 2023 17:52:24 +0100</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/

Object Caching 0/128 objects using Redis
Page Caching using Disk: Enhanced 
Lazy Loading
Database Caching using Redis (Request-wide modification query)

Served from: space.mya.co.uk @ 2026-10-01 00:06:52 by W3 Total Cache
-->